ASND logo

Ascendis Pharma A/S (ASND) Cash from investing

annual CFI:

$7.44M-$302.27M(-97.60%)
December 31, 2024

Summary

  • As of today (August 18, 2025), ASND annual cash flow from investing activities is $7.44 million, with the most recent change of -$302.27 million (-97.60%) on December 31, 2024.
  • During the last 3 years, ASND annual CFI has risen by +$138.14 million (+105.69%).
  • ASND annual CFI is now -97.60% below its all-time high of $309.71 million, reached on December 31, 2023.

Performance

ASND Cash from investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherASNDcash flow metrics

quarterly CFI:

-$4.74M-$4.00M(-540.67%)
June 1, 2025

Summary

  • As of today (August 18, 2025), ASND quarterly cash flow from investing activities is -$4.74 million, with the most recent change of -$4.00 million (-540.67%) on June 1, 2025.
  • Over the past year, ASND quarterly CFI has dropped by -$5.36 million (-865.80%).
  • ASND quarterly CFI is now -102.10% below its all-time high of $226.01 million, reached on March 31, 2023.

Performance

ASND quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherASNDcash flow metrics

TTM CFI:

-$6.39M-$5.36M(-521.59%)
June 1, 2025

Summary

  • As of today (August 18, 2025), ASND TTM cash flow from investing activities is -$6.39 million, with the most recent change of -$5.36 million (-521.59%) on June 1, 2025.
  • Over the past year, ASND TTM CFI has dropped by -$43.32 million (-117.29%).
  • ASND TTM CFI is now -102.08% below its all-time high of $307.67 million, reached on December 31, 2023.

Performance

ASND TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherASNDcash flow metrics

Cash from investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

ASND Cash from investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-97.6%-865.8%-117.3%
3 y3 years+105.7%-148.3%+88.3%
5 y5 years+228.8%+98.2%+97.7%

ASND Cash from investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-97.6%+105.7%-102.1%at low-102.1%+90.3%
5 y5-year-97.6%+102.2%-102.1%+98.2%-102.1%+98.2%
alltimeall time-97.6%+102.2%-102.1%+98.2%-102.1%+98.2%

ASND Cash from investing History

DateAnnualQuarterlyTTM
Jun 2025
-
-$4.74M(+540.7%)
-$6.39M(+521.6%)
Mar 2025
-
-$739.90K(+90.9%)
-$1.03M(-113.7%)
Dec 2024
$7.44M(-97.6%)
-$387.60K(-25.3%)
$7.48M(-32.7%)
Sep 2024
-
-$519.00K(-183.8%)
$11.11M(-69.9%)
Jun 2024
-
$619.00K(-92.0%)
$36.93M(-58.7%)
Mar 2024
-
$7.77M(+139.5%)
$89.42M(-70.9%)
Dec 2023
$309.71M(+377.4%)
$3.24M(-87.2%)
$307.67M(+1.8%)
Sep 2023
-
$25.31M(-52.4%)
$302.25M(+4.1%)
Jun 2023
-
$53.11M(-76.5%)
$290.47M(+17.5%)
Mar 2023
-
$226.01M(<-9900.0%)
$247.17M(+283.8%)
Dec 2022
$64.88M(-149.6%)
-$2.18M(-116.1%)
$64.39M(-197.7%)
Sep 2022
-
$13.53M(+37.9%)
-$65.88M(+20.2%)
Jun 2022
-
$9.81M(-77.3%)
-$54.82M(+6.8%)
Mar 2022
-
$43.24M(-132.6%)
-$51.33M(-60.8%)
Dec 2021
-$130.70M(-60.6%)
-$132.45M(-638.7%)
-$130.84M(+56.9%)
Sep 2021
-
$24.59M(+84.9%)
-$83.37M(-2.7%)
Jun 2021
-
$13.30M(-136.7%)
-$85.65M(-76.3%)
Mar 2021
-
-$36.28M(-57.3%)
-$361.47M(+8.9%)
Dec 2020
-$331.96M(+5649.0%)
-$84.98M(-480.9%)
-$331.96M(+33.7%)
Sep 2020
-
$22.31M(-108.5%)
-$248.22M(-8.7%)
Jun 2020
-
-$262.52M(+3780.4%)
-$271.92M(+2692.9%)
Mar 2020
-
-$6.77M(+444.9%)
-$9.74M(+68.6%)
Dec 2019
-$5.77M
-$1.24M(-10.8%)
-$5.77M(-0.1%)
DateAnnualQuarterlyTTM
Sep 2019
-
-$1.39M(+313.9%)
-$5.78M(+0.5%)
Jun 2019
-
-$336.50K(-88.0%)
-$5.75M(-1.1%)
Mar 2019
-
-$2.80M(+125.2%)
-$5.82M(+85.4%)
Dec 2018
-$3.12M(+194.3%)
-$1.25M(-8.7%)
-$3.14M(+44.0%)
Sep 2018
-
-$1.36M(+238.3%)
-$2.18M(+125.5%)
Jun 2018
-
-$403.10K(+221.5%)
-$966.00K(+22.7%)
Mar 2018
-
-$125.40K(-56.2%)
-$787.20K(-25.9%)
Dec 2017
-$1.06M(+42.8%)
-$286.40K(+89.5%)
-$1.06M(+19.2%)
Sep 2017
-
-$151.10K(-32.6%)
-$890.70K(-2.4%)
Jun 2017
-
-$224.30K(-43.9%)
-$912.60K(-8.4%)
Mar 2017
-
-$400.10K(+247.3%)
-$996.20K(+33.1%)
Dec 2016
-$743.40K(-35.5%)
-$115.20K(-33.4%)
-$748.20K(-28.0%)
Sep 2016
-
-$173.00K(-43.8%)
-$1.04M(+20.0%)
Jun 2016
-
-$307.90K(+102.4%)
-$866.40K(+55.1%)
Mar 2016
-
-$152.10K(-62.6%)
-$558.50K(+37.4%)
Dec 2015
-$1.15M(+114.5%)
-$406.40K(+896.1%)
-$406.40K(-24.3%)
Dec 2014
-$537.20K(-66.1%)
-$40.80K(-49.3%)
-$537.20K(-63.1%)
Sep 2014
-
-$80.40K(-67.1%)
-$1.46M(-17.3%)
Jun 2014
-
-$244.70K(+42.8%)
-$1.76M(+16.1%)
Mar 2014
-
-$171.30K(-82.2%)
-$1.52M(+12.7%)
Dec 2013
-$1.59M(+324.4%)
-$960.00K(+149.5%)
-$1.34M(+249.5%)
Sep 2013
-
-$384.80K
-$384.80K
Dec 2012
-$373.80K
-
-

FAQ

  • What is Ascendis Pharma A/S annual cash flow from investing activities?
  • What is the all time high annual CFI for Ascendis Pharma A/S?
  • What is Ascendis Pharma A/S annual CFI year-on-year change?
  • What is Ascendis Pharma A/S quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Ascendis Pharma A/S?
  • What is Ascendis Pharma A/S quarterly CFI year-on-year change?
  • What is Ascendis Pharma A/S TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Ascendis Pharma A/S?
  • What is Ascendis Pharma A/S TTM CFI year-on-year change?

What is Ascendis Pharma A/S annual cash flow from investing activities?

The current annual CFI of ASND is $7.44M

What is the all time high annual CFI for Ascendis Pharma A/S?

Ascendis Pharma A/S all-time high annual cash flow from investing activities is $309.71M

What is Ascendis Pharma A/S annual CFI year-on-year change?

Over the past year, ASND annual cash flow from investing activities has changed by -$302.27M (-97.60%)

What is Ascendis Pharma A/S quarterly cash flow from investing activities?

The current quarterly CFI of ASND is -$4.74M

What is the all time high quarterly CFI for Ascendis Pharma A/S?

Ascendis Pharma A/S all-time high quarterly cash flow from investing activities is $226.01M

What is Ascendis Pharma A/S quarterly CFI year-on-year change?

Over the past year, ASND quarterly cash flow from investing activities has changed by -$5.36M (-865.80%)

What is Ascendis Pharma A/S TTM cash flow from investing activities?

The current TTM CFI of ASND is -$6.39M

What is the all time high TTM CFI for Ascendis Pharma A/S?

Ascendis Pharma A/S all-time high TTM cash flow from investing activities is $307.67M

What is Ascendis Pharma A/S TTM CFI year-on-year change?

Over the past year, ASND TTM cash flow from investing activities has changed by -$43.32M (-117.29%)
On this page